RONIN SURGICAL CORP

RONIN SURGICAL CORP specializes in the design, development, and manufacturing of precision surgical instruments and medical devices aligned with FDA-regulated quality systems. Operating under NAICS 339112, the company focuses on high-tolerance, sterile-grade components used in minimally invasive and robotic-assisted surgical platforms. Their technical expertise includes advanced metallurgy, micro-machining, biocompatible surface treatments, and ISO 13485-compliant production workflows. The firm emphasizes design for manufacturability, traceability through lot numbering and serialization, and validation of sterilization processes to meet stringent medical device standards. Differentiators include proprietary tooling for complex geometries and in-house metrology capabilities ensuring sub-micron dimensional accuracy critical for surgical precision. No award history is available to infer specific agency relationships or program focus areas. Consequently, there is insufficient data to characterize engagement patterns with federal departments or identify recurring mission needs they support. The company’s primary industry focus is the medical device manufacturing sector, specifically within Class II and Class III device subcategories requiring rigorous design control and risk management per 21 CFR Part 820. Their market positioning centers on serving OEMs and surgical system integrators requiring certified, low-volume, high-reliability components for hospital and surgical center use. They operate within a tightly regulated environment requiring design validation, process qualification, and supplier control systems. RONIN SURGICAL CORP is structured as a small business under the 2L entity classification and is headquartered in La Jolla, California. The company holds no active government certifications such as 8(a), HUBZone, or SDVOSB. Its geographic footprint is localized to Southern California, with operations centered on advanced manufacturing facilities equipped for cleanroom assembly and regulatory documentation control. The firm positions itself as a niche supplier to the biomedical engineering ecosystem, prioritizing technical excellence over scale.